SCA
GILD icon

Secor Capital Advisors’s Gilead Sciences GILD Stock Holding History

Secor Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,980
Closed -$151K – 473
2017
Q2 		$140K Buy
+1,980
New +$132K 0.01% 434
2017
Q1 		– Sell
-35,197
Closed -$2.47M – 507
2016
Q4 		$2.52M Buy
+35,197
New +$2.62M 0.31% 95
2016
Q1 		– Sell
-14,065
Closed -$1.27M – 660
2015
Q4 		$1.42M Buy
14,065
+7,828
+126% +$815K 0.4% 48
2015
Q3 		$612K Sell
6,237
-977
-14% -$109K 0.19% 190
2015
Q2 		$845K Buy
7,214
+3,932
+120% +$430K 0.3% 114
2015
Q1 		$322K Buy
3,282
+728
+29% +$73.9K 0.13% 292
2014
Q4 		$241K Buy
+2,554
New +$264K 0.1% 313

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Secor Capital Advisors's GILD Position: Q3 2017 in Review

Secor Capital Advisors sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 1,980 shares — an estimated $151K sold.

Secor Capital Advisors first reported a position in GILD in Q4 2014 and held it in 7 quarters. The position peaked at $2.52M in Q4 2016. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Secor Capital Advisors reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 1,980 Gilead Sciences shares in Q3 2017, an estimated $151K.
  • Secor Capital Advisors first reported a position in Gilead Sciences in Q4 2014 and held it in 7 quarters.
  • Secor Capital Advisors's Gilead Sciences position peaked at $2.52M in Q4 2016.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Secor Capital Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.